Financials
- Market Capitalization 1.78 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-63.19
Fiyat/satışlar oranı
15.2
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2069 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.40 USD | +1.80% | +3.98% | +12.21% | -25.93% | 1.82 B USD | ||
| 2084 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.73 USD | -1.09% | -0.55% | +20.21% | -7.22% | 1.78 B USD | ||
| 2096 | FTRE Fortrea Holdings Inc. - Common Stock | 18.37 USD | -2.34% | +0.22% | -4.52% | +90.56% | 1.75 B USD | ||
| 2108 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.29 USD | -1.28% | -2.23% | +1.47% | +16.91% | 1.72 B USD |